23 related articles for article (PubMed ID: 38277750)
1. PHA-665752's Antigrowth and Proapoptotic Effects on HSC-3 Human Oral Cancer Cells.
Yadav AK; Wang S; Shin YM; Jang BC
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474118
[TBL] [Abstract][Full Text] [Related]
2. Clinical effects of curcumin in enhancing cancer therapy: A systematic review.
Mansouri K; Rasoulpoor S; Daneshkhah A; Abolfathi S; Salari N; Mohammadi M; Rasoulpoor S; Shabani S
BMC Cancer; 2020 Aug; 20(1):791. PubMed ID: 32838749
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of antioxidants as cancer preventives through inhibition of HIF-1 alpha activity.
Upadhyay J; Kesharwani RK; Misra K
Bioinformation; 2009 Dec; 4(6):233-6. PubMed ID: 20975915
[TBL] [Abstract][Full Text] [Related]
4. Overcoming chemotherapy resistance using pH-sensitive hollow MnO
Zhou ZH; Liang SY; Zhao TC; Chen XZ; Cao XK; Qi M; Huang YY; Ju WT; Yang M; Zhu DW; Pang YC; Zhong LP
J Nanobiotechnology; 2021 May; 19(1):157. PubMed ID: 34039370
[TBL] [Abstract][Full Text] [Related]
5. Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1.
Bae MK; Kim SH; Jeong JW; Lee YM; Kim HS; Kim SR; Yun I; Bae SK; Kim KW
Oncol Rep; 2006 Jun; 15(6):1557-62. PubMed ID: 16685395
[TBL] [Abstract][Full Text] [Related]
6. Curcumin Suppresses Hepatic Stellate Cell-Induced Hepatocarcinoma Angiogenesis and Invasion through Downregulating CTGF.
Shao S; Duan W; Xu Q; Li X; Han L; Li W; Zhang D; Wang Z; Lei J
Oxid Med Cell Longev; 2019; 2019():8148510. PubMed ID: 30800209
[TBL] [Abstract][Full Text] [Related]
7. Curcumin analog, GO-Y078, induces HO-1 transactivation-mediated apoptotic cell death of oral cancer cells by triggering MAPK pathways and AP-1 DNA-binding activity.
Chien MH; Shih PC; Ding YF; Chen LH; Hsieh FK; Tsai MY; Li PY; Lin CW; Yang SF
Expert Opin Ther Targets; 2022 Apr; 26(4):375-388. PubMed ID: 35361044
[TBL] [Abstract][Full Text] [Related]
8. RNA interference-mediated downregulation of hypoxia-inducible factor-1α inhibits angiogenesis and survival of oral squamous cell carcinoma in vitro and in vivo.
Zhou H; Fei W; Bai Y; Zhu S; Luo E; Chen K; Hu J
Eur J Cancer Prev; 2012 May; 21(3):289-99. PubMed ID: 22113109
[TBL] [Abstract][Full Text] [Related]
9. Exploring the therapeutic potential of curcumin in oral squamous cell carcinoma (HSC-3 cells): Molecular insights into hypoxia-mediated angiogenesis.
Jayaraman S; Veeraraghavan VP; Natarajan SR; Jasmine S
Pathol Res Pract; 2024 Feb; 254():155130. PubMed ID: 38277750
[TBL] [Abstract][Full Text] [Related]
10. Curcumin and analogues against head and neck cancer: From drug delivery to molecular mechanisms.
Zhao C; Zhou X; Cao Z; Ye L; Cao Y; Pan J
Phytomedicine; 2023 Oct; 119():154986. PubMed ID: 37506572
[TBL] [Abstract][Full Text] [Related]
11. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.
Wilken R; Veena MS; Wang MB; Srivatsan ES
Mol Cancer; 2011 Feb; 10():12. PubMed ID: 21299897
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro effects of curcumin on head and neck carcinoma: a systematic review.
Borges GÁ; Rêgo DF; Assad DX; Coletta RD; De Luca Canto G; Guerra EN
J Oral Pathol Med; 2017 Jan; 46(1):3-20. PubMed ID: 27219631
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
